| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Growth Disorders | 16 | 2024 | 653 | 2.030 |
Why?
|
| Turner Syndrome | 8 | 2022 | 130 | 1.920 |
Why?
|
| Diabetes Mellitus, Type 1 | 14 | 2022 | 3432 | 1.400 |
Why?
|
| Endocrine System Diseases | 2 | 2023 | 249 | 1.100 |
Why?
|
| Diabetic Ketoacidosis | 5 | 2020 | 253 | 1.070 |
Why?
|
| Endocrinology | 4 | 2015 | 441 | 0.930 |
Why?
|
| Diabetes Mellitus, Type 2 | 20 | 2024 | 12075 | 0.930 |
Why?
|
| Endocrine System | 1 | 2023 | 112 | 0.800 |
Why?
|
| Hypoglycemia | 5 | 2016 | 881 | 0.710 |
Why?
|
| Ghrelin | 1 | 2021 | 251 | 0.650 |
Why?
|
| Hunger | 1 | 2021 | 206 | 0.640 |
Why?
|
| Insulin | 16 | 2022 | 6578 | 0.630 |
Why?
|
| Nutritional Physiological Phenomena | 2 | 2016 | 362 | 0.560 |
Why?
|
| Hyperthyroidism | 4 | 2015 | 291 | 0.550 |
Why?
|
| Gigantism | 1 | 2016 | 15 | 0.540 |
Why?
|
| Growth Hormone | 13 | 2024 | 568 | 0.530 |
Why?
|
| Insulin-Secreting Cells | 4 | 2020 | 896 | 0.530 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2015 | 34 | 0.500 |
Why?
|
| Insulin-Like Growth Factor I | 7 | 2024 | 1927 | 0.490 |
Why?
|
| Dwarfism | 1 | 2016 | 137 | 0.490 |
Why?
|
| Technetium | 1 | 2015 | 321 | 0.480 |
Why?
|
| Growth | 3 | 2016 | 365 | 0.470 |
Why?
|
| Insulin Resistance | 8 | 2024 | 3941 | 0.470 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2014 | 23 | 0.460 |
Why?
|
| Peptide Hormones | 1 | 2014 | 132 | 0.440 |
Why?
|
| Child | 60 | 2024 | 79818 | 0.430 |
Why?
|
| Diabetic Retinopathy | 1 | 2022 | 1267 | 0.430 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2019 | 1206 | 0.420 |
Why?
|
| Brain Edema | 4 | 2008 | 603 | 0.410 |
Why?
|
| Puberty | 8 | 2013 | 498 | 0.410 |
Why?
|
| Child Nutrition Disorders | 1 | 2013 | 150 | 0.380 |
Why?
|
| Adolescent | 58 | 2024 | 87892 | 0.370 |
Why?
|
| Metformin | 9 | 2024 | 907 | 0.370 |
Why?
|
| Genetic Counseling | 1 | 2015 | 624 | 0.370 |
Why?
|
| Liver Diseases | 1 | 2019 | 1296 | 0.370 |
Why?
|
| Congenital Hypothyroidism | 1 | 2010 | 40 | 0.370 |
Why?
|
| Monosaccharide Transport Proteins | 5 | 2005 | 436 | 0.360 |
Why?
|
| Central Nervous System Cysts | 1 | 2010 | 56 | 0.350 |
Why?
|
| Caregivers | 1 | 2022 | 2225 | 0.340 |
Why?
|
| Blood Glucose | 18 | 2022 | 6346 | 0.330 |
Why?
|
| Obesity | 11 | 2022 | 12870 | 0.320 |
Why?
|
| Infertility, Female | 1 | 2015 | 759 | 0.320 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2013 | 565 | 0.300 |
Why?
|
| Anorexia Nervosa | 3 | 2014 | 1361 | 0.290 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2022 | 457 | 0.270 |
Why?
|
| Karyotyping | 2 | 2021 | 1171 | 0.270 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 1895 | 0.260 |
Why?
|
| Estrogens | 2 | 2010 | 1520 | 0.260 |
Why?
|
| Humans | 105 | 2024 | 758406 | 0.250 |
Why?
|
| Body Height | 8 | 2015 | 1567 | 0.250 |
Why?
|
| Puberty, Precocious | 3 | 2012 | 163 | 0.250 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 4 | 2020 | 126 | 0.230 |
Why?
|
| Galactokinase | 1 | 2004 | 17 | 0.230 |
Why?
|
| Craniopharyngioma | 1 | 2006 | 277 | 0.220 |
Why?
|
| Thyroid Function Tests | 4 | 2015 | 289 | 0.220 |
Why?
|
| Smad4 Protein | 1 | 2024 | 191 | 0.210 |
Why?
|
| Fluid Therapy | 4 | 2020 | 578 | 0.210 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 1504 | 0.210 |
Why?
|
| Monitoring, Physiologic | 1 | 2010 | 1780 | 0.210 |
Why?
|
| Hypoglycemic Agents | 6 | 2018 | 3069 | 0.200 |
Why?
|
| Liver | 6 | 2014 | 7502 | 0.200 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1313 | 0.190 |
Why?
|
| Child, Preschool | 20 | 2024 | 42062 | 0.190 |
Why?
|
| Menstruation Disturbances | 2 | 2018 | 143 | 0.190 |
Why?
|
| Fetus | 7 | 1995 | 1859 | 0.190 |
Why?
|
| Immediate-Early Proteins | 1 | 2004 | 449 | 0.190 |
Why?
|
| Growth and Development | 1 | 2021 | 47 | 0.190 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2021 | 34 | 0.180 |
Why?
|
| Glucose | 10 | 2021 | 4336 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 5 | 2010 | 5779 | 0.180 |
Why?
|
| Guideline Adherence | 1 | 2010 | 2215 | 0.180 |
Why?
|
| Immunization | 1 | 2004 | 1227 | 0.170 |
Why?
|
| Nafarelin | 5 | 1994 | 27 | 0.170 |
Why?
|
| Adenoma | 1 | 2010 | 2148 | 0.170 |
Why?
|
| Glucose Tolerance Test | 3 | 2018 | 1172 | 0.170 |
Why?
|
| Thyroxine | 2 | 2015 | 667 | 0.160 |
Why?
|
| Female | 66 | 2024 | 390323 | 0.160 |
Why?
|
| Fasting | 8 | 2018 | 1599 | 0.160 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 5816 | 0.160 |
Why?
|
| Gluconeogenesis | 4 | 1988 | 185 | 0.160 |
Why?
|
| Bariatric Surgery | 1 | 2009 | 986 | 0.160 |
Why?
|
| Celiac Disease | 2 | 2005 | 822 | 0.160 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 4673 | 0.150 |
Why?
|
| Video Games | 1 | 2020 | 191 | 0.150 |
Why?
|
| Liver Function Tests | 1 | 2019 | 523 | 0.150 |
Why?
|
| Obesity, Morbid | 1 | 2009 | 1277 | 0.150 |
Why?
|
| Body Fat Distribution | 1 | 2019 | 243 | 0.150 |
Why?
|
| Human Growth Hormone | 2 | 2015 | 638 | 0.150 |
Why?
|
| Mosaicism | 1 | 2021 | 465 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 3701 | 0.140 |
Why?
|
| Lactates | 6 | 1989 | 404 | 0.140 |
Why?
|
| Infant | 12 | 2024 | 36055 | 0.140 |
Why?
|
| Intestine, Small | 2 | 2005 | 1207 | 0.140 |
Why?
|
| Phenotype | 4 | 2024 | 16534 | 0.140 |
Why?
|
| Pediatrics | 2 | 2015 | 3587 | 0.140 |
Why?
|
| Luteinizing Hormone | 4 | 1994 | 820 | 0.130 |
Why?
|
| Subcutaneous Fat | 1 | 2019 | 393 | 0.130 |
Why?
|
| Transcription Factors | 4 | 2021 | 12094 | 0.130 |
Why?
|
| Follicle Stimulating Hormone | 3 | 1993 | 725 | 0.130 |
Why?
|
| Brain | 2 | 2022 | 26947 | 0.130 |
Why?
|
| Infant, Newborn | 9 | 2015 | 26183 | 0.120 |
Why?
|
| Testosterone | 6 | 2018 | 2471 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 5786 | 0.120 |
Why?
|
| Puberty, Delayed | 3 | 2012 | 121 | 0.120 |
Why?
|
| Circadian Rhythm | 3 | 2005 | 2567 | 0.120 |
Why?
|
| C-Peptide | 3 | 2024 | 433 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 1 | 2019 | 608 | 0.110 |
Why?
|
| Age Determination by Skeleton | 4 | 2012 | 126 | 0.110 |
Why?
|
| Pituitary Hormones | 1 | 2015 | 182 | 0.110 |
Why?
|
| Disease Outbreaks | 1 | 2003 | 1755 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 3602 | 0.110 |
Why?
|
| Male | 48 | 2024 | 358747 | 0.110 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 6520 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7378 | 0.110 |
Why?
|
| Liver Glycogen | 2 | 1992 | 35 | 0.110 |
Why?
|
| Energy Metabolism | 6 | 2010 | 2868 | 0.110 |
Why?
|
| Pregnancy, Animal | 1 | 1993 | 124 | 0.110 |
Why?
|
| Triiodothyronine | 1 | 2015 | 493 | 0.110 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2012 | 21 | 0.110 |
Why?
|
| Adrenarche | 1 | 2012 | 6 | 0.110 |
Why?
|
| RNA, Messenger | 7 | 2008 | 12759 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2022 | 2374 | 0.110 |
Why?
|
| Genetic Load | 1 | 2012 | 15 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 4 | 2012 | 1153 | 0.100 |
Why?
|
| Receptors, LHRH | 1 | 2012 | 158 | 0.100 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2012 | 104 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9574 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2010 | 415 | 0.100 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2012 | 240 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2413 | 0.090 |
Why?
|
| Estradiol | 3 | 2018 | 1933 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2001 | 3705 | 0.090 |
Why?
|
| Sheep | 3 | 1993 | 1441 | 0.090 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 8530 | 0.090 |
Why?
|
| Pregnancy | 12 | 2022 | 29742 | 0.090 |
Why?
|
| Glutamine | 1 | 1993 | 575 | 0.090 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2015 | 497 | 0.090 |
Why?
|
| Mass Screening | 2 | 2023 | 5427 | 0.090 |
Why?
|
| Islets of Langerhans | 2 | 2008 | 1345 | 0.090 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2010 | 49 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2010 | 11892 | 0.090 |
Why?
|
| Pituitary Gland | 2 | 1989 | 637 | 0.090 |
Why?
|
| Body Composition | 4 | 2009 | 2416 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 4 | 1993 | 463 | 0.080 |
Why?
|
| Fetal Diseases | 1 | 2015 | 911 | 0.080 |
Why?
|
| Prolactinoma | 1 | 2010 | 113 | 0.080 |
Why?
|
| Body Mass Index | 7 | 2020 | 12876 | 0.080 |
Why?
|
| Thiazolidinediones | 2 | 2018 | 460 | 0.080 |
Why?
|
| Response Elements | 1 | 2010 | 308 | 0.080 |
Why?
|
| Adult | 23 | 2024 | 219935 | 0.080 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2013 | 376 | 0.080 |
Why?
|
| Hypogonadism | 4 | 2012 | 800 | 0.080 |
Why?
|
| Gonadotropins | 1 | 1989 | 241 | 0.080 |
Why?
|
| Pregnancy in Diabetics | 1 | 2010 | 194 | 0.080 |
Why?
|
| Nutrition Disorders | 1 | 2009 | 205 | 0.080 |
Why?
|
| Fetal Growth Retardation | 2 | 1986 | 579 | 0.080 |
Why?
|
| Population Surveillance | 1 | 2018 | 2606 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2021 | 3530 | 0.070 |
Why?
|
| Pituitary ACTH Hypersecretion | 1 | 2010 | 178 | 0.070 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 1987 | 33 | 0.070 |
Why?
|
| Glucagon | 3 | 1981 | 532 | 0.070 |
Why?
|
| Oocytes | 2 | 2022 | 1165 | 0.070 |
Why?
|
| Animals, Newborn | 5 | 1986 | 2672 | 0.070 |
Why?
|
| Cryopreservation | 2 | 2022 | 717 | 0.070 |
Why?
|
| Thyrotropin | 1 | 2010 | 832 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1651 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 2 | 2017 | 169 | 0.070 |
Why?
|
| Electrolytes | 1 | 2008 | 274 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 1998 | 3020 | 0.070 |
Why?
|
| Hyperinsulinism | 1 | 2010 | 400 | 0.070 |
Why?
|
| Life Style | 4 | 2020 | 3886 | 0.070 |
Why?
|
| Bicarbonates | 1 | 2008 | 292 | 0.070 |
Why?
|
| Animals | 27 | 2014 | 167768 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1989 | 411 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 652 | 0.070 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 2307 | 0.070 |
Why?
|
| Preventive Medicine | 1 | 2008 | 247 | 0.070 |
Why?
|
| Testis | 1 | 1989 | 794 | 0.070 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 1986 | 39 | 0.070 |
Why?
|
| Lipoproteins | 1 | 1991 | 881 | 0.070 |
Why?
|
| Sodium-Glucose Transporter 1 | 3 | 2005 | 108 | 0.070 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 1130 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 1256 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2005 | 1543 | 0.060 |
Why?
|
| Taxes | 1 | 2008 | 221 | 0.060 |
Why?
|
| Weight Gain | 2 | 2008 | 2346 | 0.060 |
Why?
|
| Cities | 1 | 2008 | 541 | 0.060 |
Why?
|
| Iodine Radioisotopes | 1 | 2009 | 1032 | 0.060 |
Why?
|
| Base Sequence | 4 | 2009 | 12436 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2010 | 665 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1831 | 0.060 |
Why?
|
| Adiponectin | 2 | 2024 | 1114 | 0.060 |
Why?
|
| Drug Therapy, Combination | 4 | 2020 | 6293 | 0.060 |
Why?
|
| Splanchnic Circulation | 1 | 1984 | 110 | 0.060 |
Why?
|
| Thimerosal | 1 | 2004 | 15 | 0.060 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2004 | 25 | 0.060 |
Why?
|
| Animals, Suckling | 1 | 2004 | 69 | 0.060 |
Why?
|
| School Health Services | 1 | 2008 | 380 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2009 | 1694 | 0.060 |
Why?
|
| Carbamates | 1 | 2005 | 191 | 0.060 |
Why?
|
| Body Weight | 8 | 2013 | 4603 | 0.060 |
Why?
|
| Caffeine | 1 | 1989 | 701 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 7590 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2009 | 2176 | 0.060 |
Why?
|
| Sulfonylurea Compounds | 1 | 2005 | 219 | 0.060 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2004 | 132 | 0.060 |
Why?
|
| Gastrectomy | 1 | 2009 | 670 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 11070 | 0.060 |
Why?
|
| Exercise | 2 | 2020 | 5788 | 0.060 |
Why?
|
| Nutrition Policy | 1 | 2008 | 470 | 0.060 |
Why?
|
| Retrospective Studies | 8 | 2015 | 80168 | 0.060 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 1067 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2009 | 17617 | 0.060 |
Why?
|
| Facies | 1 | 2024 | 222 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2024 | 125 | 0.050 |
Why?
|
| Clubfoot | 1 | 2024 | 87 | 0.050 |
Why?
|
| Cryptorchidism | 1 | 2024 | 151 | 0.050 |
Why?
|
| Glucose Transporter Type 2 | 3 | 2005 | 61 | 0.050 |
Why?
|
| Child Development | 1 | 2015 | 2285 | 0.050 |
Why?
|
| Hand Deformities, Congenital | 1 | 2024 | 174 | 0.050 |
Why?
|
| Exons | 1 | 2009 | 2387 | 0.050 |
Why?
|
| Risk Factors | 6 | 2018 | 73809 | 0.050 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2004 | 92 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2005 | 458 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13447 | 0.050 |
Why?
|
| Binding Sites | 2 | 2004 | 6036 | 0.050 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 2210 | 0.050 |
Why?
|
| Nutritional Status | 2 | 2009 | 1607 | 0.050 |
Why?
|
| Papio | 5 | 1989 | 661 | 0.050 |
Why?
|
| Disclosure | 1 | 2008 | 738 | 0.050 |
Why?
|
| Drug Combinations | 2 | 2019 | 2020 | 0.050 |
Why?
|
| Rats | 9 | 2008 | 23679 | 0.050 |
Why?
|
| Alanine | 2 | 1984 | 603 | 0.050 |
Why?
|
| Parents | 2 | 2015 | 3548 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2004 | 568 | 0.050 |
Why?
|
| Gynecomastia | 1 | 1982 | 87 | 0.050 |
Why?
|
| Vitrification | 1 | 2022 | 51 | 0.050 |
Why?
|
| Duodenum | 1 | 2005 | 485 | 0.050 |
Why?
|
| Biology | 1 | 2024 | 289 | 0.050 |
Why?
|
| Exercise Therapy | 2 | 2019 | 919 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2014 | 2496 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2005 | 8143 | 0.050 |
Why?
|
| Cosmetics | 1 | 1982 | 102 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 39059 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 1987 | 1077 | 0.050 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 1980 | 23 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2012 | 4106 | 0.050 |
Why?
|
| Thiazoles | 2 | 2019 | 1510 | 0.040 |
Why?
|
| Myocardium | 1 | 2013 | 4690 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 3754 | 0.040 |
Why?
|
| Stress, Physiological | 3 | 2004 | 1398 | 0.040 |
Why?
|
| Carboxylic Acids | 1 | 1980 | 90 | 0.040 |
Why?
|
| Dexamethasone | 2 | 1994 | 1927 | 0.040 |
Why?
|
| Oxygen Consumption | 4 | 1989 | 1845 | 0.040 |
Why?
|
| Glucokinase | 1 | 2020 | 102 | 0.040 |
Why?
|
| Hospitals, General | 1 | 2024 | 795 | 0.040 |
Why?
|
| Hydatidiform Mole | 1 | 2002 | 254 | 0.040 |
Why?
|
| Genotype | 2 | 2024 | 12945 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2014 | 4412 | 0.040 |
Why?
|
| Plasmids | 1 | 2004 | 2275 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 1 | 1 | 1998 | 27 | 0.040 |
Why?
|
| Point Mutation | 1 | 2004 | 1593 | 0.040 |
Why?
|
| Prader-Willi Syndrome | 2 | 2010 | 76 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4284 | 0.040 |
Why?
|
| Age Factors | 5 | 2013 | 18358 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2009 | 2685 | 0.040 |
Why?
|
| Chromosomes, Human, Y | 1 | 2019 | 161 | 0.040 |
Why?
|
| Live Birth | 1 | 2022 | 512 | 0.040 |
Why?
|
| Kinetics | 3 | 2001 | 6371 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2005 | 3991 | 0.040 |
Why?
|
| Darkness | 1 | 1998 | 158 | 0.040 |
Why?
|
| Aging | 2 | 1994 | 8650 | 0.040 |
Why?
|
| Kidney | 3 | 1986 | 7016 | 0.040 |
Why?
|
| Mice | 5 | 2014 | 81101 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2010 | 2044 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1998 | 365 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 2 | 1995 | 186 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2004 | 842 | 0.040 |
Why?
|
| Weight Loss | 1 | 2009 | 2671 | 0.040 |
Why?
|
| Ketone Bodies | 1 | 1977 | 76 | 0.040 |
Why?
|
| HLA Antigens | 2 | 1981 | 1368 | 0.040 |
Why?
|
| Piperidines | 1 | 2005 | 1639 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1998 | 1055 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2004 | 1230 | 0.030 |
Why?
|
| Diet Therapy | 1 | 2018 | 150 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 415 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2009 | 2147 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2020 | 1570 | 0.030 |
Why?
|
| Cell Division | 1 | 2004 | 4458 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2004 | 5031 | 0.030 |
Why?
|
| Mutation | 4 | 2024 | 29915 | 0.030 |
Why?
|
| Androgens | 2 | 2018 | 1291 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2005 | 2118 | 0.030 |
Why?
|
| Transfection | 1 | 2004 | 5779 | 0.030 |
Why?
|
| Muscles | 1 | 1981 | 1579 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 546 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2004 | 877 | 0.030 |
Why?
|
| Protein Binding | 2 | 2004 | 9311 | 0.030 |
Why?
|
| Young Adult | 6 | 2024 | 58808 | 0.030 |
Why?
|
| Virilism | 1 | 1994 | 28 | 0.030 |
Why?
|
| Longevity | 1 | 2022 | 1050 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2907 | 0.030 |
Why?
|
| Methylglucosides | 1 | 1994 | 35 | 0.030 |
Why?
|
| 3-O-Methylglucose | 1 | 1994 | 37 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2021 | 18940 | 0.030 |
Why?
|
| Counseling | 1 | 2022 | 1541 | 0.030 |
Why?
|
| Hyperandrogenism | 1 | 1994 | 39 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2004 | 1216 | 0.030 |
Why?
|
| Overweight | 2 | 2017 | 2411 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1993 | 71 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 12604 | 0.030 |
Why?
|
| RNA | 1 | 2004 | 2716 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 1993 | 6234 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 1994 | 333 | 0.030 |
Why?
|
| Adrenal Gland Diseases | 1 | 1994 | 141 | 0.030 |
Why?
|
| Fetal Blood | 2 | 1993 | 1343 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 1098 | 0.030 |
Why?
|
| Ovarian Diseases | 1 | 1994 | 137 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1994 | 221 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 14490 | 0.030 |
Why?
|
| Uterine Neoplasms | 1 | 2002 | 1439 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 2018 | 3858 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1993 | 6354 | 0.030 |
Why?
|
| Bone Development | 2 | 2015 | 472 | 0.030 |
Why?
|
| Radioimmunoassay | 4 | 1990 | 866 | 0.030 |
Why?
|
| Diabetes Complications | 2 | 2004 | 1317 | 0.030 |
Why?
|
| Carbon Radioisotopes | 1 | 1993 | 557 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1979 | 3612 | 0.020 |
Why?
|
| Light | 1 | 1998 | 1345 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15399 | 0.020 |
Why?
|
| Eating | 2 | 2001 | 1536 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2018 | 64378 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 2292 | 0.020 |
Why?
|
| Jejunum | 2 | 2005 | 471 | 0.020 |
Why?
|
| Hypothalamic Diseases | 1 | 2012 | 134 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factors | 1 | 2010 | 5 | 0.020 |
Why?
|
| Massachusetts | 1 | 2024 | 8823 | 0.020 |
Why?
|
| Arginine | 4 | 2004 | 933 | 0.020 |
Why?
|
| Propylthiouracil | 1 | 1970 | 68 | 0.020 |
Why?
|
| Carbon Dioxide | 2 | 1989 | 1146 | 0.020 |
Why?
|
| Echocardiography | 3 | 2018 | 4962 | 0.020 |
Why?
|
| Adrenal Glands | 2 | 2012 | 554 | 0.020 |
Why?
|
| Time Factors | 4 | 2004 | 39872 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2016 | 2640 | 0.020 |
Why?
|
| Ovarian Function Tests | 1 | 1989 | 11 | 0.020 |
Why?
|
| Cardiac Output | 2 | 1984 | 837 | 0.020 |
Why?
|
| Dwarfism, Pituitary | 1 | 2010 | 39 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 12951 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 7985 | 0.020 |
Why?
|
| Dealkylation | 1 | 1989 | 2 | 0.020 |
Why?
|
| Apolipoproteins C | 1 | 2009 | 59 | 0.020 |
Why?
|
| Ketosis | 1 | 1989 | 46 | 0.020 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 1 | 1989 | 36 | 0.020 |
Why?
|
| Adiposity | 1 | 2019 | 1858 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2010 | 206 | 0.020 |
Why?
|
| Apolipoprotein C-III | 1 | 2010 | 208 | 0.020 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 1989 | 53 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1999 | 2560 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2004 | 9267 | 0.020 |
Why?
|
| Amenorrhea | 1 | 2012 | 480 | 0.020 |
Why?
|
| Haplorhini | 3 | 1977 | 529 | 0.020 |
Why?
|
| Somatomedins | 2 | 1980 | 178 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 1989 | 459 | 0.020 |
Why?
|
| Apoptosis | 1 | 2004 | 9468 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 1989 | 265 | 0.020 |
Why?
|
| Breath Tests | 1 | 1989 | 297 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2385 | 0.020 |
Why?
|
| Prolactin | 1 | 1989 | 621 | 0.020 |
Why?
|
| Acidosis | 1 | 1989 | 268 | 0.020 |
Why?
|
| Nutritional Requirements | 1 | 1988 | 275 | 0.020 |
Why?
|
| Testosterone Congeners | 1 | 1987 | 62 | 0.020 |
Why?
|
| COS Cells | 1 | 2008 | 1128 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2004 | 11471 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 1044 | 0.020 |
Why?
|
| Lipoprotein(a) | 1 | 1991 | 479 | 0.020 |
Why?
|
| Minerals | 1 | 1987 | 283 | 0.020 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Vagotomy, Truncal | 1 | 2005 | 9 | 0.020 |
Why?
|
| Sucrase | 1 | 2005 | 51 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 2451 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2018 | 3806 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2007 | 23884 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10504 | 0.020 |
Why?
|
| Ovary | 1 | 1989 | 958 | 0.020 |
Why?
|
| Secretory Rate | 2 | 1989 | 81 | 0.020 |
Why?
|
| Ligation | 1 | 1986 | 448 | 0.020 |
Why?
|
| Mental Health | 1 | 2019 | 3234 | 0.020 |
Why?
|
| Vulvovaginitis | 1 | 1984 | 14 | 0.020 |
Why?
|
| Cartilage | 2 | 1980 | 806 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1878 | 0.010 |
Why?
|
| Clitoris | 1 | 1984 | 35 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1986 | 2090 | 0.010 |
Why?
|
| Potassium Deficiency | 1 | 2004 | 9 | 0.010 |
Why?
|
| Placenta | 1 | 1993 | 1702 | 0.010 |
Why?
|
| Birth Weight | 1 | 2012 | 2097 | 0.010 |
Why?
|
| Hormones | 1 | 1987 | 869 | 0.010 |
Why?
|
| Transglutaminases | 1 | 2005 | 197 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 15773 | 0.010 |
Why?
|
| Hydroxybutyrates | 2 | 1989 | 79 | 0.010 |
Why?
|
| Sex Characteristics | 2 | 2009 | 2621 | 0.010 |
Why?
|
| Mathematics | 1 | 1984 | 707 | 0.010 |
Why?
|
| Ammonia | 1 | 1984 | 236 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10146 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2004 | 622 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2015 | 3891 | 0.010 |
Why?
|
| Thymidine | 2 | 1980 | 299 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10748 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 2 | 2002 | 457 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 165 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 5484 | 0.010 |
Why?
|
| Antithyroid Agents | 1 | 2002 | 72 | 0.010 |
Why?
|
| Urea | 1 | 1984 | 444 | 0.010 |
Why?
|
| Uterus | 1 | 1986 | 651 | 0.010 |
Why?
|
| Phosphates | 2 | 2004 | 771 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2004 | 588 | 0.010 |
Why?
|
| Myocardial Contraction | 2 | 1987 | 1516 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3812 | 0.010 |
Why?
|
| Phlorhizin | 1 | 2001 | 37 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22029 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1984 | 282 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4567 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2017 | 41256 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1984 | 1486 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2010 | 4257 | 0.010 |
Why?
|
| Guanosine | 1 | 2001 | 48 | 0.010 |
Why?
|
| Temperature | 1 | 1987 | 2219 | 0.010 |
Why?
|
| Diet Fads | 1 | 1980 | 13 | 0.010 |
Why?
|
| Catheterization | 1 | 1986 | 1426 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2010 | 3441 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2001 | 405 | 0.010 |
Why?
|
| Thorax | 1 | 2003 | 553 | 0.010 |
Why?
|
| Methyltestosterone | 1 | 1979 | 19 | 0.010 |
Why?
|
| Organ Size | 1 | 1984 | 2252 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2013 | 5460 | 0.010 |
Why?
|
| Rickets | 1 | 1980 | 71 | 0.010 |
Why?
|
| Lactic Acid | 1 | 1984 | 1133 | 0.010 |
Why?
|
| Sulfates | 1 | 1980 | 379 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2002 | 403 | 0.010 |
Why?
|
| Osteocalcin | 1 | 1999 | 274 | 0.010 |
Why?
|
| Alkaline Phosphatase | 2 | 1999 | 865 | 0.010 |
Why?
|
| DNA | 1 | 2012 | 7199 | 0.010 |
Why?
|
| United States | 3 | 2003 | 72136 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 1980 | 304 | 0.010 |
Why?
|
| Extremities | 1 | 2003 | 865 | 0.010 |
Why?
|
| Olfaction Disorders | 1 | 1980 | 224 | 0.010 |
Why?
|
| Acetoacetates | 1 | 1977 | 19 | 0.010 |
Why?
|
| Reference Values | 1 | 2005 | 4919 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2013 | 54137 | 0.010 |
Why?
|
| Abdomen | 1 | 2003 | 1129 | 0.010 |
Why?
|
| Europe | 1 | 2004 | 3420 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1981 | 1446 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1987 | 4087 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1989 | 8553 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 1240 | 0.010 |
Why?
|
| Veins | 1 | 1980 | 765 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 1999 | 579 | 0.010 |
Why?
|
| Glycerol | 1 | 1977 | 275 | 0.010 |
Why?
|
| Anthropometry | 1 | 1980 | 1347 | 0.010 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1999 | 409 | 0.010 |
Why?
|
| Culture Media | 2 | 1992 | 899 | 0.010 |
Why?
|
| Adipose Tissue | 2 | 2003 | 3299 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1987 | 2244 | 0.010 |
Why?
|
| Arteries | 1 | 1980 | 1125 | 0.010 |
Why?
|
| Vitamin D | 2 | 1987 | 3283 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 15591 | 0.010 |
Why?
|
| Physical Examination | 1 | 1980 | 1245 | 0.010 |
Why?
|
| Oxandrolone | 1 | 1973 | 24 | 0.010 |
Why?
|
| Hydrolases | 1 | 1994 | 146 | 0.010 |
Why?
|
| Heart | 1 | 1987 | 4382 | 0.010 |
Why?
|
| Sleep | 1 | 1989 | 4744 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 1999 | 1735 | 0.010 |
Why?
|
| Phosphorylases | 1 | 1992 | 17 | 0.010 |
Why?
|
| Glycogen Synthase | 1 | 1992 | 61 | 0.010 |
Why?
|
| Amygdala | 2 | 1971 | 1350 | 0.010 |
Why?
|
| Cerebral Cortex | 3 | 1977 | 5759 | 0.010 |
Why?
|
| Spine | 1 | 1999 | 1111 | 0.010 |
Why?
|
| Epitopes | 1 | 1979 | 2502 | 0.010 |
Why?
|
| Leptin | 1 | 1999 | 1591 | 0.010 |
Why?
|
| Hypopituitarism | 1 | 1973 | 250 | 0.010 |
Why?
|
| Breast Feeding | 1 | 1980 | 1355 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7583 | 0.010 |
Why?
|
| Biological Transport | 1 | 1995 | 2084 | 0.010 |
Why?
|
| Parathyroid Glands | 1 | 1972 | 517 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1999 | 1868 | 0.010 |
Why?
|
| Prognosis | 1 | 1990 | 29557 | 0.010 |
Why?
|
| DNA Replication | 1 | 1976 | 1410 | 0.010 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1989 | 139 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1989 | 74 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1994 | 733 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14354 | 0.000 |
Why?
|
| Calcium | 2 | 1999 | 5721 | 0.000 |
Why?
|
| Octreotide | 1 | 1989 | 153 | 0.000 |
Why?
|
| Ketones | 1 | 1989 | 183 | 0.000 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1989 | 128 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17768 | 0.000 |
Why?
|
| Aldosterone | 1 | 1972 | 866 | 0.000 |
Why?
|
| Basal Metabolism | 1 | 1988 | 161 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1977 | 2731 | 0.000 |
Why?
|
| Aged | 1 | 2019 | 168218 | 0.000 |
Why?
|
| Chick Embryo | 2 | 1980 | 981 | 0.000 |
Why?
|
| Bone Density | 1 | 1999 | 3533 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22003 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 219568 | 0.000 |
Why?
|
| Argininosuccinate Synthase | 1 | 1984 | 15 | 0.000 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 1984 | 17 | 0.000 |
Why?
|
| Benzoic Acid | 1 | 1984 | 16 | 0.000 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1984 | 23 | 0.000 |
Why?
|
| Phenylacetates | 1 | 1984 | 112 | 0.000 |
Why?
|
| Models, Biological | 1 | 1981 | 9460 | 0.000 |
Why?
|
| Algorithms | 1 | 2005 | 13961 | 0.000 |
Why?
|
| Diarrhea | 1 | 1970 | 1317 | 0.000 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1984 | 303 | 0.000 |
Why?
|
| Benzoates | 1 | 1984 | 211 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1984 | 555 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2005 | 23342 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1984 | 1378 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1981 | 516 | 0.000 |
Why?
|
| Syndrome | 2 | 1980 | 3262 | 0.000 |
Why?
|
| Energy Intake | 1 | 1988 | 2127 | 0.000 |
Why?
|
| Colorimetry | 2 | 1971 | 148 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1972 | 2457 | 0.000 |
Why?
|
| Abnormalities, Multiple | 2 | 1980 | 1414 | 0.000 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1971 | 392 | 0.000 |
Why?
|
| Exercise Test | 1 | 1987 | 2121 | 0.000 |
Why?
|
| Blood | 1 | 1980 | 586 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1979 | 553 | 0.000 |
Why?
|
| Sexual Maturation | 1 | 1979 | 260 | 0.000 |
Why?
|
| Biological Assay | 1 | 1980 | 626 | 0.000 |
Why?
|
| Chromosome Disorders | 1 | 1980 | 499 | 0.000 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1980 | 351 | 0.000 |
Why?
|
| Species Specificity | 2 | 1971 | 2417 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1984 | 4839 | 0.000 |
Why?
|
| Heart Rate | 1 | 1987 | 4166 | 0.000 |
Why?
|
| Leucine | 1 | 1976 | 547 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1984 | 1786 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1980 | 1763 | 0.000 |
Why?
|
| Methods | 1 | 1972 | 1074 | 0.000 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1973 | 169 | 0.000 |
Why?
|
| Vitamins | 1 | 1980 | 1632 | 0.000 |
Why?
|
| Umbilical Cord | 1 | 1972 | 181 | 0.000 |
Why?
|
| Diet, Sodium-Restricted | 1 | 1972 | 291 | 0.000 |
Why?
|
| Renin | 1 | 1972 | 635 | 0.000 |
Why?
|
| Risk | 1 | 1981 | 9599 | 0.000 |
Why?
|
| Diuretics | 1 | 1972 | 610 | 0.000 |
Why?
|
| Sodium | 1 | 1972 | 1588 | 0.000 |
Why?
|
| Postpartum Period | 1 | 1972 | 1167 | 0.000 |
Why?
|
| Delivery, Obstetric | 1 | 1972 | 932 | 0.000 |
Why?
|
| Diet | 1 | 1972 | 8005 | 0.000 |
Why?
|